Page last updated: 2024-09-04

bdp 12 and ly 404187

bdp 12 has been researched along with ly 404187 in 5 studies

Compound Research Comparison

Studies
(bdp 12)
Trials
(bdp 12)
Recent Studies (post-2010)
(bdp 12)
Studies
(ly 404187)
Trials
(ly 404187)
Recent Studies (post-2010) (ly 404187)
6271432010

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, MB; Baker, SR; Bleakman, D; Bleisch, TJ; Cantrell, B; Deverill, M; Gates, M; Ho, K; Jarvie, KR; Kamboj, RK; Mandelzys, A; Ornstein, PL; Simon, R; Tizzano, JP; Zarrinmayeh, H; Zimmerman, DM1
Grove, SJ; Jamieson, C; Maclean, JK; Morrow, JA; Rankovic, Z1
Bleakman, D; Gates, MR; Grabell, J; Gupta, A; Ho, K; Jarvie, KR; Miu, P; Ogden, A; Ornstein, PL; Peters, D; Radhakrishnan, V; Zarrinmayeh, H; Zimmerman, DM1
Bond, A; Huff, K; Lodge, D; Vandergriff, J1
Baumbarger, PJ; Muhlhauser, M; Nisenbaum, ES; Yang, CR; Zhai, J1

Other Studies

5 other study(ies) available for bdp 12 and ly 404187

ArticleYear
Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors.
    Journal of medicinal chemistry, 2000, Nov-16, Volume: 43, Issue:23

    Topics: Cell Line; Humans; Receptors, AMPA; Structure-Activity Relationship; Sulfonamides

2000
Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.
    Journal of medicinal chemistry, 2010, Oct-28, Volume: 53, Issue:20

    Topics: Allosteric Regulation; Animals; Benzamides; Benzothiadiazines; Binding Sites; Excitatory Amino Acid Agents; Humans; Indazoles; Ligands; Models, Molecular; Protein Conformation; Receptors, AMPA; Sulfonamides

2010
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.
    Neuropharmacology, 2001, Volume: 40, Issue:8

    Topics: Allosteric Regulation; Antihypertensive Agents; Benzothiadiazines; Calcium; Cell Line; Dioxoles; Dose-Response Relationship, Drug; Drug Synergism; Electrophysiology; Excitatory Amino Acid Agonists; Humans; Piperidines; Receptors, AMPA; Receptors, Glutamate; Recombinant Proteins; Sulfonamides; Thiophenes

2001
Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo.
    Neuropharmacology, 2001, Volume: 40, Issue:8

    Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dioxoles; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Female; Hippocampus; Injections, Intravenous; Male; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Spinal Cord; Stereotaxic Techniques; Sulfonamides; Thiophenes

2001
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:1

    Topics: Allosteric Regulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Dioxoles; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Piperidines; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Sulfonamides

2001